HUMAN METAPNEUMOVIRUS (HMPV)

• Recently, cases of Human Metapneumovirus (HMPV) have emerged in China, raising concern among health officials.
• As respiratory infections rise in the winter months, China’s disease control authorities have launched a monitoring system for pneumonia of unknown origin.
• This system aims to help track and manage new pathogens.
• One of the key viruses detected is HMPV, which has shown an upward trend, especially in northern provinces and among children under 14.
• Although social media posts suggested that China had declared an emergency over HMPV, there has been no official confirmation of such a declaration.
• However, authorities are carefully monitoring the situation as respiratory infections are expected to increase through winter and spring.

WHAT IS HUMAN METAPNEUMOVIRUS? A model structure of Human Metapneumovirus Human Metapneumovirus (HMPV) is a respiratory virus that causes infections similar to the common cold. It was first identified in 2001 and belongs to the Pneumoviridae family, which also includes:

• Respiratory Syncytial Virus (RSV)
• Measles
• Mumps

HMPV can affect both the upper (nose, throat) and lower respiratory tract (lungs) and is most commonly seen during the winter and early spring months. Children, the elderly, and people with weakened immune systems are at a higher risk of infection and complications. SIGNS & SYMPTOMS The symptoms of HMPV typically resemble those of a common cold but can range from mild to more severe. Common symptoms include:

• Cough
• Runny or blocked nose
• Sore throat
• Fever
• Wheezing

The incubation period for HMPV is generally 3 to 6 days. In most cases, the infection resolves on its own within a few days with rest and supportive care at home. However, in some individuals, complications like bronchitis or pneumonia can develop, requiring medical treatment. HOW DOES HMPV SPREAD? HMPV is primarily spread through respiratory droplets when an infected person coughs or sneezes. It can also be transmitted via:

• Close contact with an infected person (e.g., shaking hands, hugging)
• Touching contaminated objects (e.g., doorknobs, phones, keyboards) and then touching your mouth, nose, or eyes

Because the virus spreads through these common actions, personal hygiene is crucial in preventing transmission. TREATMENT OF HMPV Currently, there is no specific antiviral medication to treat HMPV, nor is there a vaccine for prevention. Treatment focuses on managing symptoms. Most people recover with the help of:

• Over-the-counter medications for fever and pain relief
• Decongestants to ease breathing difficulties

Since antibiotics are ineffective against viral infections, they are not prescribed for HMPV unless there is a secondary bacterial infection. PREVENTION OF HMPV Preventing the spread of HMPV largely involves general precautions to avoid respiratory infections:

• Frequent hand washing with soap and water
• Avoid close contact with infected individuals
• Avoid touching your face, particularly the eyes, nose, and mouth
• Wearing a mask if you suspect you may be infected, to prevent spreading the virus to others

People with pre-existing lung conditions, such as asthma or Chronic Obstructive Pulmonary Disease (COPD), should take extra care to avoid exposure to the virus.

MONITORING & RESPONSE: INDIA’S VIGILANCE

• In response to reports from China, India’s National Centre for Disease Control (NCDC) under the Union Health Ministry is actively monitoring respiratory infections and seasonal influenza cases within the country.
• The NCDC is also in touch with international health agencies to stay updated on the situation.
• According to official sources, while there has been a rise in acute respiratory infections (including HMPV, RSV, and seasonal influenza) in China during December, the overall scale and intensity of these diseases is reportedly lower than in the previous year.
• Health officials expect a seasonal increase in respiratory pathogens across the northern hemisphere during the winter period.